Case-control studies of cancers of the bladder, kidney, prostate, pancreas, esophagus, stomach, lung, brain, and head and neck, as well as non-Hodgkins lymphoma and multiple myeloma, are in progress. Two large case-control studies of kidney cancer are ongoing in the United States and in Eastern Europe to identify risk factors for kidney cancer. Results from the U.S. study suggest that a family history of kidney cancer is associated with a doubling of kidney cancer risk. These findings were similar in Caucasians and African Americans. In contrast, chronic hepatitis C virus infection was not related to kidney cancer risk in the Swedish population. In a cohort study of Chinese women, family history of colorectal cancer was associated with a tripling of colorectal cancer risk. In a pooled analysis of data from 10 case-control studies and two cohort studies, cigarette smoking was associated with increased risks of adenocarcinoma of the esophagus and esophagogastric junction in white men and women. Moreover, smoking cessation was shown to be associated with reduced risks of these sites. In a case-control study of gallbladder cancer in Shanghai, high parity, younger age at first birth, and late age at menarche were associated with increased risk, particularly among women with biliary stones. In addition, among participants who smoked and drank alcohol, a history of gastric or duodenal ulcers was associated with an excess of gallbladder cancer, supporting a role for inflammation in the etiology of gallbladder cancer. In a pooled analysis of data from eight case-control studies, sexual behaviors were associated with risk of cancer of the head and neck subsites that have previously been associated with HPV infection. In a second pooled analysis of 13 case-control studies, cessation of tobacco smoking and cessation of alcohol drinking appeared to reduce risk of head and neck cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIACP010136-16
Application #
8349567
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
2011
Total Cost
$1,152,632
Indirect Cost
Name
Division of Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
Zip Code
Bock, Cathryn H; Ruterbusch, Julie J; Holowatyj, Andreana N et al. (2018) Renal cell carcinoma risk associated with lower intake of micronutrients. Cancer Med 7:4087-4097
Kuijpers, Eelco; Pronk, Anjoeka; Kleemann, Robert et al. (2018) Cardiovascular effects among workers exposed to multiwalled carbon nanotubes. Occup Environ Med 75:351-358
Suarez-Sarmiento, Alfredo; Yao, Xiaopan; Hofmann, Jonathan N et al. (2017) Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system. Int J Urol 24:765-770
Zhang, Yuan; Hofmann, Jonathan N; Purdue, Mark P et al. (2017) Logistic Bayesian LASSO for genetic association analysis of data from complex sampling designs. J Hum Genet 62:819-829
Purdue, Mark P; Stewart, Patricia A; Friesen, Melissa C et al. (2017) Occupational exposure to chlorinated solvents and kidney cancer: a case-control study. Occup Environ Med 74:268-274
Liao, Linda M; Hofmann, Jonathan N; Cho, Eunyoung et al. (2017) Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial. Cancer Causes Control 28:801-807
Santo, Loredana; Teras, Lauren R; Giles, Graham G et al. (2017) Circulating resistin levels and risk of multiple myeloma in three prospective cohorts. Br J Cancer 117:1241-1245
Hofmann, Jonathan N; Mailankody, Sham; Korde, Neha et al. (2017) Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease. Obesity (Silver Spring) 25:1317-1320
Colt, Joanne S; Hofmann, Jonathan N; Schwartz, Kendra et al. (2017) Antihypertensive medication use and risk of renal cell carcinoma. Cancer Causes Control 28:289-297
Schwartz, Kendra; Ruterbusch, Julie J; Colt, Joanne S et al. (2016) Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors. Cancer Med 5:200-8

Showing the most recent 10 out of 55 publications